≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Burkitt lymphoma, including Hilmo

Endpoint Browser

C3_BURKITT_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

  • HLP_C3_BURKITT
30

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C83.70, C83.71
  • Hospital discharge: ICD-9 — 2002A
  • Cause of death: ICD-10 — C83.70, C83.71
  • Cause of death: ICD-9 — 2002A
  • Cancer registry: Topography ICD-O-3 — C42|C77
  • Cancer registry: Morphology ICD-O-3 — 9687|9826
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

30

4. Check minimum number of events

None

30

5. Include endpoints

30

6. Filter based on genotype QC (FinnGen only)

29

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE
Control conditions
not HLP_C3_BURKITT

Extra metadata

First used in FinnGen datafreeze
DF12
Parent code in ICD-10
C81-C96
Name in latin
Lymphoma non-Hodgkin diffusum

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 29 7 22
Unadjusted period prevalence (%) 0.01 0.00 0.01
Median age at first event (years) 41.00 39.74 41.41

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
19
37
12.28
11.10
1.8
1.5
—
—
—
0
0
12
7
27.16
8.98
1.4
1.3
—
—
—
0
0
8
0
+∞
8.74
12.8
0.0
0.22
—
umol/l
—
8
0
19
48
9.07
8.46
1.7
2.1
—
—
—
0
0
19
49
8.85
8.26
9.7
4.9
—
—
—
0
0
17
32
10.81
7.77
1.6
1.5
—
—
—
0
0
7
0
+∞
7.59
2.9
0.0
—
—
—
0
0
7
0
+∞
7.59
1.0
0.0
—
—
—
0
0
15
24
11.34
7.42
1.5
1.4
—
—
—
0
0
12
12
15.70
7.37
2.9
1.2
1.23
1.19
g/l
0.04
12
12
19
65
6.24
5.75
12.9
2.0
315.37
12992.90
umol/l
0.79
19
58
15
44
5.82
5.30
1.7
3.0
—
—
—
0
0
8
7
14.93
5.12
3.9
1.3
306.13
571.29
mg/l
—
8
7
8
7
14.93
5.12
3.6
1.1
3.77
3.64
mmol/l
—
8
7
24
114
6.49
4.99
25.9
4.7
—
—
—
0
0
25
130
6.51
4.55
21.2
5.9
0.13
0.22
e9/l
2.79
20
110
9
14
8.64
4.37
1.4
1.1
—
—
—
0
0
11
25
6.31
4.14
2.3
4.5
—
—
—
0
0
17
66
4.64
4.11
8.3
2.0
—
—
—
0
0
22
116
4.34
3.46
4.5
2.9
0.00
0.00
estimate
—
5
26
6
8
9.00
3.21
1.3
1.3
—
—
—
0
0
6
8
9.00
3.21
5.0
1.3
4.05
1.90
ug/l
—
6
8
22
121
4.05
3.11
32.8
7.8
0.01
0.00
e9/l
0.60
16
91
21
116
3.69
2.83
6.5
4.2
0.00
0.00
estimate
—
5
23
7
15
5.73
2.78
1.4
1.0
—
—
—
0
0
5
8
7.21
2.47
2.8
1.3
21.20
20.88
s
—
5
8
16
79
3.20
2.43
7.4
3.2
7.03
16.15
e6/l
0.67
11
58
13
57
3.26
2.39
4.3
2.5
—
—
—
0
0
23
151
3.23
2.17
6.0
3.5
—
—
—
0
0
14
68
2.99
2.13
5.6
2.3
—
—
—
0
0
8
28
3.51
2.04
15.4
14.1
—
—
—
0
0
13
62
2.94
2.03
2.2
1.4
—
—
—
0
0
5
11
5.21
2.02
1.2
1.4
—
—
—
0
0
25
175
3.56
2.01
7.1
3.6
13.28
9.72
mm/h
0.74
25
160
7
23
3.64
1.94
1.4
2.3
—
—
—
0
0
13
64
2.82
1.89
31.6
5.4
—
—
—
0
0
5
13
4.38
1.79
2.6
5.9
—
—
—
0
0
5
14
4.06
1.68
4.0
2.1
—
—
—
0
0
12
60
2.67
1.67
2.1
1.4
—
—
—
0
0
7
27
3.06
1.63
3.3
2.5
—
—
—
0
0
7
27
3.06
1.63
18.6
7.0
23.90
25.98
mmol/l
—
7
27
7
29
2.83
1.50
9.1
11.6
102.29
103.93
mmol/l
—
7
29
6
23
3.00
1.45
20.7
4.4
26.83
24.39
mmol/l
—
6
23
5
17
3.31
1.42
3.4
4.9
4.61
5.20
kpa
—
5
17
8
38
2.50
1.31
15.9
4.4
—
—
—
0
0
8
38
2.50
1.31
16.0
3.8
5.30
1.59
mmol/l
—
8
27
19
129
2.29
1.28
11.1
9.0
6.28
6.66
mmol/l
0.36
19
118
9
45
2.42
1.19
3.9
2.6
586.11
550.85
mosm/kgh2o
—
9
39
7
38
2.09
0.81
2.6
2.0
—
—
—
0
0
10
63
1.88
0.73
4.0
2.9
—
—
—
0
0
5
84
0.52
0.69
2.2
2.6
—
—
—
0
0
6
37
1.77
0.60
2.3
1.7
1137.33
1276.04
nmol/l
—
6
30
22
241
0.67
0.46
4.3
4.1
2.74
2.72
mmol/l
0.04
22
223
0
16
0.00
0.42
0.0
1.1
—
6.82
—
0
10
0
16
0.00
0.42
0.0
1.1
—
9.15
—
0
10
0
16
0.00
0.42
0.0
1.1
—
5.48
—
0
10
7
51
1.48
0.35
5.7
3.7
—
—
—
0
0
22
239
0.70
0.32
4.0
3.7
4.38
4.50
mmol/l
0.25
22
220
0
10
0.00
0.22
0.0
1.2
—
4.85
—
0
5
0
10
0.00
0.22
0.0
4.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
5
67
0.70
0.19
1.0
1.8
1.63
1.27
mmol/l
—
5
56
21
223
0.81
0.18
4.1
3.6
1.37
1.30
mmol/l
0.18
21
202
17
152
1.27
0.18
4.8
3.3
—
—
—
0
0
23
217
1.26
0.17
58.2
14.6
15.97
13.77
%
0.85
23
212
22
205
1.27
0.17
4.5
4.2
2.14
2.00
mu/l
0.18
22
183
0
8
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
6.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.5
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BURKITT_WIDE – Burkitt lymphoma, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).